What is Nomegestrol Acetate?

Written by The Lowdown

|

Medically reviewed by Dr Fatema Dawoodbhoy

on Sep 13, 2024

What's the lowdown?

  • Nomegestrol acetate is a synthetic progesterone used in oral contraception or hormonal replacement therapy

  • Nomegestrol acetate in combination with ethinyl estradiol is sold under the brand name Zoely 

  • Prolonged use of nomegestrol acetate has been linked to an increased risk of developing intracranial meningiomas

     

  • Nomegestrol acetate has mild androgenic effects on the body

Nomegestrol acetate is a synthetic progestin that was first licensed for use in 2011. It’s also used in some hormonal therapies for menopausal women.

It is used in the combined pill alongside ethinyl estradiol, a synthetic oestrogen, and taken orally. It has a half-life of around 50 hours.

How does Nomegestrol Acetate work?

Nomegestrol acetate prevents ovulation by suppressing lutenising hormone1. When combined with the oestrogen ethinyl estradiol it can also thicken the cervical fluid to stop sperm from entering your uterus, and can thin the lining of your womb so that a fertilised egg can’t implant.  If taken correctly, it is 99% effective in preventing pregnancy.

What is it in?

Combined pill

  • Zoely

Is Nomegestrol Acetate androgenic?

No – in fact, it is mildly anti-androgenic1. (Check out our ‘Androgens’ blog for more info on what this means).

Nomegestrol Acetate side effects

The following side effects have been reported for nomegestrol acetate2:

  • Unusual menstrual bleeding
  • Absence of a withdrawal bleed
  • Acne
  • Weight change
  • Mood changes 
  • Headaches/Migraines
  • Loss of libido
  • Nausea 
  • Breast tenderness
  • Pelvic pain

Data taken from self reported Lowdown Zoely user reviews in September 2024 shows that 31% experienced period-like cramps, 19% felt nauseous, 44% had lighter periods, and 31% noticed a positive change in mood. 63% reported no effect on sex drive, 75% mentioned no impact on weight and 56% said it had no impact on their skin.

Meningioma risk

There has been some research showing that nomegestrol acetate increases the risk of developing intracranial meningiomas. This is a benign (non-cancerous) brain or spinal cord tumour that can grow slowly oftentimes not causing symptoms. It is recommended that women who used nomegestrol acetate should be advised of these risks and regularly screened for meningiomas3.

    References

    Social Logo Lowdown

    The Lowdown

    We are a real-word evidence platform for women’s health that’s visited by almost 2 million women every year. We enable women to review and research their health conditions, symptoms and medications so they can make more informed decisions. Our approach is unique; we provide credible, scientific information alongside reviews from our community of women. We believe that listening to women’s experiences of healthcare is crucial to improving it. Any articles written by "The Lowdown" are written by a range of Lowdown team members and medical professionals.

    Our medical review process

    This article has been medically reviewed for factual and up to date information by a Lowdown doctor.